10-Year Free Cash Flow Projections(showing years 1, 3, 5, 7, 10)
| Year | Year 1 | Year 3 | Year 5 | Year 7 | Year 10 |
|---|
| Revenue | $297.5B | $343.3B | $384.1B | $417.7B | $456.5B |
| EBIT | $13.9B | $16.0B | $17.9B | $36.5B | $56.1B |
| Tax | $3.5B | $4.0B | $4.5B | $9.2B | $14.1B |
| NOPAT | $10.4B | $12.0B | $13.4B | $27.3B | $42.0B |
| + Depreciation | $2.3B | $2.6B | $2.9B | $3.2B | $3.5B |
| - Capex | $4.8B | $5.5B | $6.1B | $6.7B | $7.3B |
| - Δ NWC | $2.2B | $2.4B | $1.8B | $1.6B | $1.1B |
| Free Cash Flow | $5.6B | $6.7B | $8.3B | $22.2B | $37.0B |
| Discount Factor | 0.918 | 0.774 | 0.653 | 0.551 | 0.426 |
| Present Value | $5.2B | $5.2B | $5.4B | $12.2B | $15.8B |
FCF Formula: Free Cash Flow = NOPAT + Depreciation - Capex - Change in Net Working Capital
Sensitivity AnalysisPrice per Share
| WACC ↓ / Growth → | 1.50% | 2.00% | 2.50% | 3.00% | 3.50% |
|---|
| 6.90% | $1,341.62 | $1,384.84 | $1,437.88 | $1,504.53 | $1,590.77 |
| 7.90% | $1,172.72 | $1,200.57 | $1,233.58 | $1,273.33 | $1,322.10 |
| 8.90% | $1,038.58 | $1,057.54 | $1,079.46 | $1,105.09 | $1,135.47 |
| 9.90% | $928.36 | $941.80 | $957.04 | $974.50 | $994.69 |
| 10.90% | $835.63 | $845.45 | $856.44 | $868.82 | $882.87 |
How to read: This table shows how the valuation changes with different WACC (discount rate) and terminal growth rate assumptions. Green = undervalued, Red = overvalued.
Key Assumptions & Drivers✓ Using Analyst Consensus Estimates• Consumer Defensive Sector
Growth Assumptions (Select Years)
Year 1 Revenue Growth8.08%
Year 3 Revenue Growth7.36%
Year 5 Revenue Growth5.05%
Year 7 Revenue Growth4.03%
Year 10 Revenue Growth2.50%
Terminal Growth Rate2.50%
Margin & Efficiency
Current EBIT Margin4.66%
Terminal EBIT Margin16.00%
Tax Rate25.13%
Historical Capex / Rev1.60%
NWC / Revenue10.00%
Key Drivers: Revenue growth, operating margin expansion, capex efficiency, and working capital management are the primary drivers of cash flow generation. Terminal value assumptions significantly impact final valuation.
Institutional-Grade Methodology
Actual Company Data: Revenue, EBIT, Capex, NWC, Tax Rate, Interest Expense, Beta
Market Assumptions: Risk-free: 4.5% (10Y), MRP: 4.5% (Damodaran 2026), Exit: 20x EV/EBITDA (Consumer Defensive sector)
This DCF model is for informational purposes only. Projections are based on assumptions that may not materialize. Past performance does not guarantee future results. Consult a financial advisor before making investment decisions.